Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
23,630 total articles
ANI Pharmaceuticals announced the publication of results from the NEW DAY clinical trial involving their ILUVIEN implant for diabetic macular edema (DME) in a leading ophthalmology journal. This publication reinforces the clinical evidence supporting ILUVIEN's use in appropriate DME patients, highlighting the company's commitment to advancing treat…
Fennec Pharmaceuticals announced that the University of Arizona Cancer Center is initiating an investigator-sponsored Phase I/II study evaluating the efficacy of PEDMARK® (sodium thiosulfate injection) in adolescent, young adult, and adult patients with solid tumors receiving cisplatin chemotherapy to prevent hearing loss. This study complements ot…
Invivyd, Inc. announced a national education campaign called Antibodies for Any Body in partnership with skier Lindsey Vonn to raise public awareness about antibodies and their role in immune health. The campaign features an interactive wellness assessment on AntibodiesforAnyBody.com designed to empower individuals to understand how lifestyle habit…
Uniti Solutions, a business unit of Uniti, has been awarded the Americas Service Provider of the Year at the 2026 Cato Networks Americas Partner Awards for the second year in a row. The recognition highlights their effective collaboration in delivering managed SASE services powered by Cato's SASE platform, improving secure networking for their cust…
Dole Food Company celebrates the 125th anniversary of its pineapple legacy with a series of events, product launches, and sustainability programs highlighting its commitment to environmental stewardship, social equity, and community support, including new initiatives at its pineapple farms and expanded product offerings.
WW International, Inc., the global leader in science-backed weight management, announced the appointment of Lisa Gavales and Sue Gove as independent directors to its Board. Both bring extensive experience in consumer brands, retail leadership, e-commerce, financial oversight, and public company governance. These strategic additions aim to support W…
NervGen Pharma announced the successful conclusion of the End-of-Phase 2 meeting with the FDA, securing alignment on the RESTORE Phase 3 registrational study evaluating NVG-291 for chronic tetraplegia. The FDA-endorsed study design includes a functional primary endpoint focused on hand use improvement, with initiation planned for mid-2026. Positive…
CervoMed Inc. announced new MRI analysis findings from its Phase 2b RewinD-LB clinical trial showing potential benefits of neflamapimod in reducing basal forebrain atrophy in DLB patients. The company also reported alignment with global regulatory authorities on its Phase 3 trial design and highlighted neflamapimod's potential as the first approved…
Palvella Therapeutics announced the appointment of Kent Taylor as Senior Vice President of Sales to spearhead the U.S. sales organization in preparation for the potential launch of QTORIN™ rapamycin, targeting rare, serious skin diseases and vascular malformations. Taylor brings over 25 years of pharmaceutical sales leadership, including successful…
Cognition Therapeutics, a clinical-stage biopharmaceutical company focused on neurodegenerative disorders, announced its CEO will present progress on its lead drug candidate, zervimesine (CT1812), at the 25th Annual Needham Virtual Healthcare Conference. Zervimesine, an oral treatment currently in Phase 2 trials, has shown promise for dementia with…
Plus Therapeutics announced that the American Medical Association has granted a new Proprietary Laboratory Analyses (PLA) code 0640U for its CNSide® CSF Tumor Cell Enumeration test, facilitating reimbursement and supporting the commercial launch in the U.S. This coding milestone is expected to enhance payer coverage, clinical adoption, and revenue …
Creative Realities, Inc., a Nasdaq-listed provider of digital signage, media and AdTech solutions, announced it will release its financial results for the quarter and full year ended December 31, 2025, on April 14, 2026, prior to market open. The company will host a conference call with management to discuss the results and business outlook. The an…
Univest Financial Corporation will release its first quarter 2026 earnings after market close on April 22, 2026, followed by a conference call for discussion on April 23, 2026. The company, based in Pennsylvania, is a regional financial institution offering banking, insurance, investment, and finance services primarily in the Mid-Atlantic region.
Akamai Technologies announced it will hold its first quarter 2026 earnings conference call on May 7, 2026, at 4:30 p.m. ET. The call will cover the company's financial results for Q1 2026 and may include forward-looking guidance from management. The event will be accessible via live dial-in and webcast, with a replay available for two weeks followi…
Artelo Biosciences, Inc., a clinical-stage pharmaceutical company, announced that it has regained compliance with Nasdaq listing requirements. The company highlighted progress in its clinical pipeline, including the ART27.13 candidate showing potential for cancer anorexia-cachexia syndrome and glaucoma, and ART26.12 for neuropathic pain. Management…
Wrap Technologies, Inc. announced that the Galveston Police Department has adopted its non-lethal response solutions by purchasing BolaWrap 150 devices and subscribing to WrapTactics training, supported by in-person training sessions. This move aims to enhance the department's capabilities in managing critical incidents with safer, non-lethal tools…
NextCure, Inc. announced that the FDA has granted Fast Track designation to its investigational therapy SIM0505 for treating platinum-resistant ovarian cancer. SIM0505 is an antibody drug conjugate targeting Cadherin-6, currently in Phase 1 trials, with dose optimization expected in Q2 2026 and Phase 1 data to be presented at ASCO 2026. The Fast Tr…
Toll Brothers, the leading luxury home builder listed on NYSE as TOL, announced the final availability of quick move-in luxury homes at their StoneCreek community in Richmond, Texas. The neighborhood features elegant homes with resort-style amenities and convenient access to Houston, targeting families and professionals seeking upscale living.
Emergent BioSolutions launches a compact, durable carrying case for NARCAN nasal spray and expands multipack options to improve accessibility of its opioid overdose reversal product. The company also initiates a college campus campaign featuring Emmitt Smith to promote overdose preparedness, targeting high-risk young adults and encouraging wider ca…
Sysco Corporation, the global leader in food distribution for the food-away-from-home market, will announce its third quarter fiscal year 2026 financial results on April 28, 2026. The company will host a webcast and conference call and provide an investor presentation, offering detailed financial performance insights.
Dillard's, Inc. (NYSE: DDS) announced a new collaboration with designer Cydney Morris to create the limited-edition Cyd Morris x Gianni Bini capsule collection. The exclusive collection features apparel and accessories inspired by coastal nostalgia and is available only at Dillard's stores and online. This partnership enriches Dillard's contemporar…
Eldorado Gold Corporation announced that its shareholders approved the issuance of common shares in connection with the proposed acquisition of Foran Mining Corporation. This transaction will add the McIlvenna Bay asset to Eldorado's portfolio, enhancing its position as a disciplined, growth-oriented gold and copper producer. The deal awaits final …
Akebia Therapeutics will hold one-on-one investor meetings at the Raymond James 2026 Biotech Innovation Symposium to discuss its commercial products and pipeline data showcased at its recent R&D Day. No company presentations are planned at the event.
LeMaitre Vascular, Inc., a developer and manufacturer of vascular devices for peripheral vascular disease treatment, announced its upcoming management presentation at the 25th Annual Needham Virtual Healthcare Conference scheduled for April 16, 2025.
Nutanix announced new enhancements to its Elevate Service Provider Program, including the upcoming Service Provider Central platform enabling multitenancy on the Nutanix Cloud Platform, aimed at helping service providers scale and differentiate their cloud services. Additionally, Nutanix is offering onboarding incentives to encourage service provid…
